Women more prone to selected oesophagogastric cancer chemotherapy side-effects
Men and women may need to be treated differently – at least when it comes to some types of cancer.
ESMO Media Releases
One in six premenopausal early breast cancer patients do not adhere to hormonal therapy
Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy after one year of treatment
ESMO Women for Oncology Forum focuses on power sharing to foster gender equality
The Women for Oncology (W4O) Forum at ESMO 2018, Sharing The Power, on Friday, 19 October*, will focus on power sharing between women and men working in oncology as a way of fostering gender equality.
ESMO advocacy for patient-centred care takes on global dimension
Supportive and palliative care should be an integral part of cancer treatment, the European Society for Medical Oncology claimed in its position paper.
Financial impacts of cancer found to intensify disease burden among German patients
A study conducted in Germany draws attention to the fact that the socio-economic burden of cancer is real in Europe
Breast cancer patients use Twitter as a non-medical forum to share their experiences
Twitter is a place where many cancer patients go to share and discuss their experiences of the disease
Trust in non-conventional therapies by cancer patients not matched with proper awareness about their risks
Sarcoma patients show great openness to the use of complementary alternative medicines (CAMs) for supportive care, but they are poorly informed about safety issues and risk of interactions with anti-cancer drugs.
Targeted drugs for advanced cancer move from specialist units to community setting
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours.
ESMO 2018 Congress Media Alert
Reporters are invited to follow the ESMO 2018 Congress, the leading international oncology event in Europe, beginning on Friday 19 October at the Messe München in Munich, Germany.
ESMO 2018 Awardees announced
ESMO, the leading organisation for medical oncology, has revealed the four distinguished oncology professionals who will receive its annual awards during the ESMO 2018 Congress, 19-23 October, Munich, Germany.
Following the tumour DNA trail to crack the secrets of personalised medicine
Individualised therapies that target the specific genetic features of tumours have the potential to transform cancer diagnosis, treatment and care.
Men and women are different: Why medical oncology needs to restate the obvious
At the ESMO workshop, “Gender medicine meets oncology”, to be held in Lausanne, Switzerland, on 30 November and 1 December 2018, a multidisciplinary faculty of experts will discuss the concepts and methods of gender medicine and their implications for clinical practice and research in oncology.